| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/01/2004 | WO2004027412A1 Sensor for monitoring an analyte |
| 04/01/2004 | WO2004027410A1 Method and system for measuring oxygen and water concentration in hydrogen through ion mobility spectrometry |
| 04/01/2004 | WO2004027398A1 Method and apparatus for quantitative analysis of a turbid, pharmaceutical sample |
| 04/01/2004 | WO2004027391A1 Blood analyzer and method of separating plasma |
| 04/01/2004 | WO2004027389A2 Assay products and procedures |
| 04/01/2004 | WO2004027388A2 Novel green and orange fluorescent labels and their uses |
| 04/01/2004 | WO2004027387A2 Automated regression analysis and its applications such as water analysis |
| 04/01/2004 | WO2004027386A2 Thermal analysis of energetic materials |
| 04/01/2004 | WO2004027382A2 Sensor assemblies and methods of securing elongated members within such assemblies |
| 04/01/2004 | WO2004027381A2 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 04/01/2004 | WO2004027379A2 Methods and devices for active bioassay |
| 04/01/2004 | WO2004027378A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | WO2004027377A2 Electroactive microspheres and methods |
| 04/01/2004 | WO2004027374A2 Method for using division arrested cells in screening assays |
| 04/01/2004 | WO2004027372A2 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma |
| 04/01/2004 | WO2004027364A1 A system and method for measuring one or more properties of a gas |
| 04/01/2004 | WO2004027095A1 Controlled alignment of nanobarcodes encoding specific information for scanning probe microscopy (spm) reading |
| 04/01/2004 | WO2004027094A2 Assay for camp based on exclusive binding of camp to the b-binding sites of camp dependent protein kinase (capk) |
| 04/01/2004 | WO2004027093A1 Molecular arrays and single molecule detection |
| 04/01/2004 | WO2004027091A1 Method for detecting biomolecules |
| 04/01/2004 | WO2004027084A1 Detection of biological molecules by differential partitioning of enzyme substrates and products |
| 04/01/2004 | WO2004027071A1 Method of producing and screening antibodies produced in transgenic plants |
| 04/01/2004 | WO2004027061A1 Method of screening remedy for proliferative disease |
| 04/01/2004 | WO2004027059A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis |
| 04/01/2004 | WO2004027040A2 Devices and methods for isolating and recovering target cells |
| 04/01/2004 | WO2004027034A2 Methods for assessing the ability of hiv patients to restrict hiv replication |
| 04/01/2004 | WO2004027028A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 04/01/2004 | WO2004027021A2 Device and methods for isolating target cells |
| 04/01/2004 | WO2004027020A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 04/01/2004 | WO2004027018A2 Inducible focal adhesion kinase cell assay |
| 04/01/2004 | WO2004026931A2 Functionalized materials and methods of using same |
| 04/01/2004 | WO2004026909A2 Method of treating rheumatoid arthritis by interfering with expression of dc-sign by macrophages and diagnosis thereof |
| 04/01/2004 | WO2004026908A1 Wnt MEDIATED ErbB SIGNALLING, COMPOSITIONS AND USES RELATED THERETO |
| 04/01/2004 | WO2004026904A1 Rfamide-related peptide precursor proteins and rfamide peptides |
| 04/01/2004 | WO2004026820A2 Method for assaying compounds that decrease the activity of poly(adp-ribose)-polymerase (parp) |
| 04/01/2004 | WO2004026697A2 System and method of storing and retrieving storage elements |
| 04/01/2004 | WO2004026427A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 04/01/2004 | WO2004026333A1 Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-ϝ |
| 04/01/2004 | WO2004026327A1 Homing peptides to receptors of heart vasculature |
| 04/01/2004 | WO2004026120A2 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 04/01/2004 | WO2004026114A2 Quantification of carnitine levels in dialysis patients |
| 04/01/2004 | WO2004026109A2 Molecular targets of cancer and aging |
| 04/01/2004 | WO2004026026A1 7f4 gene transgenic animal |
| 04/01/2004 | WO2004021012A3 Method of diagnosis of pregnancy-related complications |
| 04/01/2004 | WO2004019045A3 Method for the diagnosis of alzheimer disease |
| 04/01/2004 | WO2004016804A3 Assay for detection of antigen in bodily fluid |
| 04/01/2004 | WO2004016766A3 Real time measurement of cellular responses |
| 04/01/2004 | WO2004016759A3 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/01/2004 | WO2004014781A3 Liquid beverage conductivity detecting system |
| 04/01/2004 | WO2004013631A3 Compositions and methods for diagnosis and therapy of cancer |
| 04/01/2004 | WO2004010143A3 Electrochemical lateral flow and flow-through devices |
| 04/01/2004 | WO2004010103A3 Impedance based devices and methods for use in assays |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007555A3 Detection of prion disease |
| 04/01/2004 | WO2004005881A3 Methods for identification of compounds modulating insulin resistance |
| 04/01/2004 | WO2004005880A3 Analyzing method for activity of thyroid autoantibody |
| 04/01/2004 | WO2003106962A3 A coated film laminate having an electrically conductive surface |
| 04/01/2004 | WO2003106703A3 Homogenous assay for enzymatic activity |
| 04/01/2004 | WO2003106498A3 Ox40 (=cd134) receptor agonistic and therapeutic use |
| 04/01/2004 | WO2003104685A3 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof |
| 04/01/2004 | WO2003103613A3 Induction of insulin expression |
| 04/01/2004 | WO2003100436A3 Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10) |
| 04/01/2004 | WO2003100420A3 Electrochemical enzyme immunoassay for simultaneously detecting a number of analytes |
| 04/01/2004 | WO2003100412A3 Method of ore treatment |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2003099868B1 Method for obtaining anti-idiotype antibodies |
| 04/01/2004 | WO2003098217A3 Novel arrangement for binding sites of a dna chip |
| 04/01/2004 | WO2003096022A3 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 04/01/2004 | WO2003095967A3 Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) |
| 04/01/2004 | WO2003093827A3 Diagnostics and drug screening for diseases associated with leucine-rich repeat-containing g-protein coupled receptor 7 (lgr7) |
| 04/01/2004 | WO2003093442A3 Cell cultures from animal models of alzheimer's disease for screening and testing drug efficacy |
| 04/01/2004 | WO2003091845A3 Microarray performance management system |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087838A3 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 04/01/2004 | WO2003085179A3 Spinning preparation machine with microwave sensors |
| 04/01/2004 | WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 04/01/2004 | WO2003083124A3 Peptide epitopes common to antigens of the same multigene family |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003082098A3 Improving performance of an analyte monitoring device |
| 04/01/2004 | WO2003081253A3 Electrochemical multi-well plate |
| 04/01/2004 | WO2003081238A3 Cytocapacity test |
| 04/01/2004 | WO2003080209A3 Method of concentrating macromolecules or agglomerates of molecules or particles |
| 04/01/2004 | WO2003079149A3 Blood clotting predictor |
| 04/01/2004 | WO2003076903A3 Articles of manufacture and methods for making hydrophobic derivatized arrays |
| 04/01/2004 | WO2003075742A3 Biomarker for efficacy of appetite suppressant drugs |
| 04/01/2004 | WO2003074069A3 Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
| 04/01/2004 | WO2003073105A3 Use of plag1 and plagl2 in cancer diagnosis and drug screening |
| 04/01/2004 | WO2003072821A3 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 04/01/2004 | WO2003070907A3 Novel fungal lipase |
| 04/01/2004 | WO2003069305A3 Fluorescent phospholipase assay, phospholipase a2 inhibitor and stimulator, and the use thereof |
| 04/01/2004 | WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins |
| 04/01/2004 | WO2003063770A3 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 04/01/2004 | WO2003062819A3 Water- soluble derivatives of lipophilic drugs |
| 04/01/2004 | WO2003062418B1 Method and apparatus for detecting nucleic acid data |
| 04/01/2004 | WO2003060100A3 CRYSTALLIZED DnaG PRIMASE COMPLEXES AND METHODS OF USE THEREOF |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003054546A3 Diagnostic signal amplification with proteinoid microspheres |
| 04/01/2004 | WO2003054226A3 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |